Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
Tóm tắt
Over the past 20 years, the tissue inhibitors of metalloproteinases (TIMPs) have been implicated in direct regulation of cell growth and apoptosis. However, the mechanisms of these effects have been controversial. Recent work by several laboratories has identified specific signaling pathways and cell surface binding partners for members of the TIMP family. TIMP-2 binding to the integrin α 3 β 1 is the first description of a cell surface receptor for a TIMP family member. TIMP-2 has been shown to induce gene expression, to promote G 1 cell cycle arrest, and to inhibit cell migration. TIMP-1 binding to CD63 inhibits cell growth and apoptosis. These new findings suggest that TIMPs are multifunctional and can act either directly through cell surface receptors or indirectly through modulation of protease activity to direct cell fate. The emerging concept is that TIMPs function in a contextual fashion so that the mechanism of action depends on the tissue microenvironment.
Từ khóa
Tài liệu tham khảo
Y. A. DeClerck, N. Perez, H. Shimada, T. C. Boone, K. E. Langley, S. M. Taylor, Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52, 701–708 (1992).1732058
A. M. Montgomery, B. M. Mueller, R. A. Reisfeld, S. M. Taylor, Y. A. DeClerck, Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res. 54, 5467–5473 (1994).7923181
P. D. Brown, Matrix metalloproteinase inhibitors. Angiogenesis 1, 142–154 (1998).14517381
J. C. Gasson, N. Bersch, D. W. Golde, Characterization of purified human erythroid-potentiating activity. Prog. Clin. Biol. Res. 184, 95–104 (1985).3931094
Z. Pasieka, H. Stepien, W. Czyz, L. Pomorski, K. Kuzdak, Concentration of metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in the serum of patients with benign and malignant thyroid tumours treated surgically. Endocr. Regul. 38, 57–63 (2004).15497929
G. Li, R. Fridman, H. R. Kim, Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res. 59, 6267–6275 (1999).10626822
X. W. Liu, M. E. Taube, K. K. Jung, Z. Dong, Y. J. Lee, S. Roshy, B. F. Sloane, R. Fridman, H. R. Kim, Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: A potential oncogenic activity of tissue inhibitor of metalloproteinase-1. Cancer Res. 65, 898–906 (2005).15705888
Y. Jiang, M. Wang, M. Y. Celiker, Y. E. Liu, Q. X. Sang, I. D. Goldberg, Y. E. Shi, Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res. 61, 2365–2370 (2001).11289097
K. H. Kang S. Y. Park S. B. Rho J. H. Lee Tissue inhibitor of metalloproteinases-3 interacts with angiogtensin II type receptor and additively inhibits angiogensis. Cardiovasc. Res. published online in press.
B. Anand-Apte, M. S. Pepper, E. Voest, R. Montesano, B. Olsen, G. Murphy, S. S. Apte, B. Zetter, Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest. Ophthalmol. Vis. Sci. 38, 817–823 (1997).9112976
E. Vairaktaris, C. Yapijakis, A. Yiannopoulos, S. Vassiliou, Z. Serefoglou, A. Vylliotis, E. Nkenke, S. Derka, E. Critselis, D. Avgoustidis, F. W. Neukam, E. Patsouris, Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. Oncol. Rep. 17, 963–968 (2007).17342343